Details for New Drug Application (NDA): 211823
✉ Email this page to a colleague
The generic ingredient in OSELTAMIVIR PHOSPHATE is oseltamivir phosphate. There are eight drug master file entries for this compound. Thirty-five suppliers are listed for this compound. Additional details are available on the oseltamivir phosphate profile page.
Summary for 211823
Tradename: | OSELTAMIVIR PHOSPHATE |
Applicant: | Alembic |
Ingredient: | oseltamivir phosphate |
Patents: | 0 |
Pharmacology for NDA: 211823
Mechanism of Action | Neuraminidase Inhibitors |
Medical Subject Heading (MeSH) Categories for 211823
Suppliers and Packaging for NDA: 211823
Tradename | Generic Name | Dosage | NDA | Application Type | Supplier | National Drug Code | Package Code | Package |
---|---|---|---|---|---|---|---|---|
OSELTAMIVIR PHOSPHATE | oseltamivir phosphate | CAPSULE;ORAL | 211823 | ANDA | Alembic Pharmaceuticals Limited | 46708-413 | 46708-413-10 | 1 CARTON in 1 BLISTER PACK (46708-413-10) / 10 CAPSULE in 1 CARTON |
OSELTAMIVIR PHOSPHATE | oseltamivir phosphate | CAPSULE;ORAL | 211823 | ANDA | Alembic Pharmaceuticals Limited | 46708-414 | 46708-414-10 | 1 CARTON in 1 BLISTER PACK (46708-414-10) / 10 CAPSULE in 1 CARTON |
Profile for product number 001
Active Rx/OTC/Discontinued: | RX | Dosage: | CAPSULE;ORAL | Strength | EQ 30MG BASE | ||||
Approval Date: | Jun 24, 2019 | TE: | AB | RLD: | No |
Profile for product number 002
Active Rx/OTC/Discontinued: | RX | Dosage: | CAPSULE;ORAL | Strength | EQ 45MG BASE | ||||
Approval Date: | Jun 24, 2019 | TE: | AB | RLD: | No |
Profile for product number 003
Active Rx/OTC/Discontinued: | RX | Dosage: | CAPSULE;ORAL | Strength | EQ 75MG BASE | ||||
Approval Date: | Jun 24, 2019 | TE: | AB | RLD: | No |
Complete Access Available with Subscription